Noyavision Pharmaceutical Group

Noyavision Pharmaceutical Group is dedicated to advancing healthcare through the development, manufacturing, and distribution of high-quality pharmaceutical and consumer healthcare products. Established in 2006, Noyavision Pharmaceutical Group offers comprehensive pharmaceutical services, transforming scientific concepts into innovative treatments. The company's expertise spans clinical studies, regulatory affairs, consulting, and market access, all driven by a profound commitment to improving patient outcomes.

Headquartered in Tehran, Noyavision Pharmaceutical Group operates as a specialty pharmaceutical company, enhancing the health of individuals worldwide through affordable, superior medicines. With a focus on educating stakeholders about healthier living, Noyavision Pharmaceutical Group maintains a strong presence across the pharmaceutical value chain. The primary address of Noyavision Pharmaceutical Group is No. 1, 22th St., Azadegan Blv., Kordestan Highway, Tehran, IR.

Noyavision Pharmaceutical Group's business model includes acquiring products from partners, co-developing treatments, and innovating through an internal R&D team. Guided by stringent internal and international quality standards such as GMP, GDP, and GSP, Noyavision Pharmaceutical Group ensures that research, production, marketing, and sales consistently meet customer needs. The company strives to maintain a secure quality management system across all operations. We invite the manager of Noyavision Pharmaceutical Group to create a customized and exclusive company showcase and product listing on our platform.